Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
Chatal
Jean-François
JF
Kraeber-Bodéré
Françoise
F
Barbet
Jacques
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D006801:Humans; D008224:Lymphoma, Follicular / Q000532:radiotherapy*; D018365:Neoplasm, Residual; D016499:Radioimmunotherapy / Q000379:methods* / Q000639:trends; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D019275:Radiopharmaceuticals; D000069283:Rituximab; C422802:ibritumomab tiuxetan; C119496:tositumomab I-131